TRIZIVIR 300 mg/150 mg/300 mg TABLETA RECUBIERTA
Country: Peru
Language: Spanish
Source: DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
SULFATO DE ABACAVIR; LAMIVUDINA; ZIDOVUDINA;
Available from:
GLAXOSMITHKLINE PERU S.A.
ATC code:
J05AR04
INN (International Name):
SULFATE ABACAVIR; LAMIVUDINE; ZIDOVUDINE;
Pharmaceutical form:
TABLETA RECUBIERTA
Composition:
POR TABLETA; LAMIVUDINA 150.000000 mg; ZIDOVUDINA 300.000000 mg; SULFATO DE ABACAVIR 351.000000 mg;
Administration route:
ORAL
Units in package:
Caja de cartón conteniendo 1, 2, 5, 10, 30, 40, 50 y 60 tabletas recubiertas en envase blister de PVC/ACLAR/PVC-Aluminio(blanco-
Prescription type:
CON RECETA MEDICA
Manufactured by:
GLAXO OPERATIONS UK LIMITED
Therapeutic group:
ZIDOVUDINA, LAMIVUDINA Y ABACAVIR
Product summary:
Presentacion: Caja de cartón conteniendo 1, 2, 5, 10, 30, 40, 50 y 60 tabletas recubiertas en envase blister de PVC/PCTFE / PVC de color blanco - Aluminio.
Authorization status:
VIGENTE
Authorization date:
2022-11-21
